Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

NCT01120223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Scalp Psoriasis

Interventions

DRUG: LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)

Sponsor

LEO Pharma